BSECian Healthcare LtdMediumNeutral
Announced Mon, 24 Nov · 19:28 IST

Annual Report of the Company for FY 2024-2025.

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Cian Healthcare has filed its 22nd Annual Report for FY 2024-25 along with the notice for its Annual General Meeting, scheduled for December 17, 2025 at 10:00 AM via video conferencing. The company is currently under Corporate Insolvency Resolution Process (CIRP), with Resolution Professional Mr. Roshen Chordiya running the operations since August 14, 2024. The Committee of Creditors (COC) had unanimously approved a resolution plan submitted by Mr. Pradeep Kumar Jain on May 9, 2025, which was filed with the NCLT Mumbai Bench on May 23, 2025. The NCLT has reserved its order on the resolution plan approval on November 6, 2025, and the final order is awaited. AGM business includes adopting the audited financial statements, appointing KNGC and Associate LLP as Secretarial Auditors for five years (FY 2025-30) at a proposed fee of Rs. 75,000, and ratifying the cost auditor's remuneration of Rs. 45,000 for FY 2025-26.

Likely market impact

The stock remains under significant overhang from the ongoing insolvency process. The next major trigger is the awaited NCLT order approving the resolution plan, which could materially affect shareholding structure and shareholder value. Until the order is pronounced, existing shareholders face uncertainty, as resolution plans typically involve restructuring, possible dilution, or changes in control.